Profile
Bobby Reddy is the founder of Prenosis, Inc. He is currently the Chief Executive Officer & Director at ElectroCyt, Inc.
Bobby Reddy active positions
| Companies | Position | Start |
|---|---|---|
ElectroCyt, Inc.
 ElectroCyt, Inc. Packaged SoftwareTechnology Services ElectroCyt, Inc. develops and provides a handheld platform for cell counting. Its products include LifeCounts, complete blood counts and specific cell counts. The company was founded by Umer Hassan and Rashid Bashir and is headquartered in Champaign, IL. | Chief Executive Officer | - |
Prenosis, Inc.
 Prenosis, Inc. Packaged SoftwareTechnology Services The American company is devoted to ushering in a new era of precision medicine in acute care. Prenosis' immunix™ precision diagnostics and evidence generation platform leverages machine learning algorithms trained on deep biological data and broad clinical data designed to capture and illuminate the complex health states of patients more holistically. The company's proprietary dataset is one of the largest and fastest-growing hybrid biomarker-clinical datasets for sepsis care. Prenosis enables physicians, providers, payers, and pharma to understand patients' unique biology and see people differently. The company was founded by Bobby Reddy and Rashid Bashir, and Bobby Reddy has been the CEO since incorporation. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
ElectroCyt, Inc.
ElectroCyt, Inc. Packaged SoftwareTechnology Services ElectroCyt, Inc. develops and provides a handheld platform for cell counting. Its products include LifeCounts, complete blood counts and specific cell counts. The company was founded by Umer Hassan and Rashid Bashir and is headquartered in Champaign, IL. | Technology Services |
Prenosis, Inc.
Prenosis, Inc. Packaged SoftwareTechnology Services The American company is devoted to ushering in a new era of precision medicine in acute care. Prenosis' immunix™ precision diagnostics and evidence generation platform leverages machine learning algorithms trained on deep biological data and broad clinical data designed to capture and illuminate the complex health states of patients more holistically. The company's proprietary dataset is one of the largest and fastest-growing hybrid biomarker-clinical datasets for sepsis care. Prenosis enables physicians, providers, payers, and pharma to understand patients' unique biology and see people differently. The company was founded by Bobby Reddy and Rashid Bashir, and Bobby Reddy has been the CEO since incorporation. | Technology Services |
- Stock Market
- Insiders
- Bobby Reddy
